Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC

Clinical trial NCT02394795 · COMPLETED

Trial details

NCT number: NCT02394795
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2015-05-29
Primary completion: 2022-01-14
Enrollment: 823

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.